Axoltis Pharma announces to attend the 11th World Congress for NeuroRehabilitation (WFNR annual meeting) jointly with the 35th Congress of the French Society of Physical and Rehabilitation Medecine annual (SOFMER annual meeting) (digital on October 7-11th 2020). Axoltis Pharma researcher team is proud to present 4 posters (#P0211, #P0212, #P0368, #P0651) demonstrating the efficacy of its innovative drug candidate, a SCO-spondin derived peptide, in cognitive impairement and traumatic spinal cord injury.